-
1
-
-
84887068801
-
Pharmaceutical expenditure. As percentage of total expenditure on health
-
OECD
-
OECD Pharmaceutical expenditure. As percentage of total expenditure on health. Health: Key Tables from OECD 2013, 10.1787/pharmexp-table-2013-1-en.
-
(2013)
Health: Key Tables from OECD
-
-
-
2
-
-
79959752316
-
Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States
-
Vogler S., Habl C., Bogut M., Voncina L. Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States. Croatian Medical Journal 2011, 52:183-197.
-
(2011)
Croatian Medical Journal
, vol.52
, pp. 183-197
-
-
Vogler, S.1
Habl, C.2
Bogut, M.3
Voncina, L.4
-
5
-
-
4344684763
-
-
Open University Press, Maidenhead, UK
-
Mossialos E., Mrazek M., et al. Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity and Quality 2004, Open University Press, Maidenhead, UK. http://www.euro.who.int/__data/assets/pdf_file/0008/98432/E83015.pdf.
-
(2004)
Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity and Quality
-
-
Mossialos, E.1
Mrazek, M.2
-
6
-
-
84887055363
-
-
WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies
-
Glossary of Pharmaceutical Terms 2011, WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies. http://whocc.goeg.at/Glossary/Search.
-
(2011)
Glossary of Pharmaceutical Terms
-
-
-
7
-
-
83555163611
-
External price referencing in Europe - a descriptive overview of one policy with many national characteristics
-
Leopold C., Vogler S., et al. External price referencing in Europe - a descriptive overview of one policy with many national characteristics. Health Policy 2012, 104(1):50-60. 10.1016/j.healthpol.2011.09.008.
-
(2012)
Health Policy
, vol.104
, Issue.1
, pp. 50-60
-
-
Leopold, C.1
Vogler, S.2
-
8
-
-
84924572521
-
Short- and long-term effects of value-based pricing versus external price referencing
-
Kanavos P., Nicod E., Espin J., van den Aardweg S. Short- and long-term effects of value-based pricing versus external price referencing. EMINet 2010, http://whocc.goeg.at/Literaturliste/Dokumente/FurtherReading/Short-%20and%20long-term%20effect%20of%20value-based%20pricing.pdf.
-
(2010)
EMINet
-
-
Kanavos, P.1
Nicod, E.2
Espin, J.3
van den Aardweg, S.4
-
10
-
-
84864376612
-
Discounts and rebates granted to public payers for medicines in European countries
-
Vogler S., Zimmerman N., Piessnegger J., Bucsics A. Discounts and rebates granted to public payers for medicines in European countries. Southern Med Review 2012, 5(1):38-46.
-
(2012)
Southern Med Review
, vol.5
, Issue.1
, pp. 38-46
-
-
Vogler, S.1
Zimmerman, N.2
Piessnegger, J.3
Bucsics, A.4
-
11
-
-
84887058979
-
Internationale Arzneimittelpreisvergleiche: meta-analyse
-
Rosian I., Vogler S., Stürzlinger H. Internationale Arzneimittelpreisvergleiche: meta-analyse. Pharmig 2004, http://whocc.goeg.at/Publications/BooksReports.
-
(2004)
Pharmig
-
-
Rosian, I.1
Vogler, S.2
Stürzlinger, H.3
-
12
-
-
2142825070
-
International differences in drug prices
-
Wagner J.L., McCarthy E. International differences in drug prices. Annual Review Public Health 2004, 25:475-495. 10.1146/annurev.publhealth.25.101802.123042.
-
(2004)
Annual Review Public Health
, vol.25
, pp. 475-495
-
-
Wagner, J.L.1
McCarthy, E.2
-
13
-
-
0034070190
-
Cross national price differences for pharmaceuticals: how large and why
-
Danzon P.M., Chao L.W. Cross national price differences for pharmaceuticals: how large and why. Journal of Health Economics 2000, 19:159-195.
-
(2000)
Journal of Health Economics
, vol.19
, pp. 159-195
-
-
Danzon, P.M.1
Chao, L.W.2
-
14
-
-
84879127131
-
-
The Institute for Research in Economics and Business Administration, Bergen, SNF report no. 08/10
-
Brekke K.R., Holmås T.H., Straume O.R. Are Pharmaceuticals Still Inexpensive in Norway? A Comparison of Prescription Drug Prices in Ten European Countries 2010, The Institute for Research in Economics and Business Administration, Bergen, SNF report no. 08/10.
-
(2010)
Are Pharmaceuticals Still Inexpensive in Norway? A Comparison of Prescription Drug Prices in Ten European Countries
-
-
Brekke, K.R.1
Holmås, T.H.2
Straume, O.R.3
-
15
-
-
36348988465
-
International comparison of generic medicine prices
-
Simoens S. International comparison of generic medicine prices. Current Medical Research and Opinion 2007, 23(11):2647-2654.
-
(2007)
Current Medical Research and Opinion
, vol.23
, Issue.11
, pp. 2647-2654
-
-
Simoens, S.1
-
16
-
-
58149522302
-
Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis
-
Cameron A., Ewen M., Ross-Degnan D., Ball D., Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. The Lancet 2009, 373(9659):240-249.
-
(2009)
The Lancet
, vol.373
, Issue.9659
, pp. 240-249
-
-
Cameron, A.1
Ewen, M.2
Ross-Degnan, D.3
Ball, D.4
Laing, R.5
-
17
-
-
84971324457
-
The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors
-
von der Schulenberg F., Vanderos S., Kanavos P. The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors. Health Economics Review 2011, 1(18). http://www.healtheconomicsreview.com/content/1/1/18.
-
(2011)
Health Economics Review
, vol.1
, Issue.18
-
-
von der Schulenberg, F.1
Vanderos, S.2
Kanavos, P.3
-
19
-
-
0023322117
-
Price elasticity and adverse selection in the demand for supplementary health insurance
-
Marquis M.S., Phelps C.E. Price elasticity and adverse selection in the demand for supplementary health insurance. Economic Inquiry 1987, 25:299-313.
-
(1987)
Economic Inquiry
, vol.25
, pp. 299-313
-
-
Marquis, M.S.1
Phelps, C.E.2
-
20
-
-
84881754373
-
Why parallel imports of pharmaceutical products should be forbidden
-
Vicién F. Why parallel imports of pharmaceutical products should be forbidden. European Competition Law Review 1996, 17:219-224.
-
(1996)
European Competition Law Review
, vol.17
, pp. 219-224
-
-
Vicién, F.1
-
22
-
-
3042621068
-
The intensity of competition after patent expiry in pharmaceuticals: a cross-country analysis
-
Pammolli F., Magazzini L., Orsenigo L. The intensity of competition after patent expiry in pharmaceuticals: a cross-country analysis. Revue of Economie Industrielle 2002, 99:107-132.
-
(2002)
Revue of Economie Industrielle
, vol.99
, pp. 107-132
-
-
Pammolli, F.1
Magazzini, L.2
Orsenigo, L.3
-
23
-
-
3042677393
-
Dynamic competition in pharmaceuticals: on patent expiry, generic penetration and industry structure
-
Magazzini L., Pammolli F., Riccaboni M. Dynamic competition in pharmaceuticals: on patent expiry, generic penetration and industry structure. European Journal of Health Economics 2004, 5:175-182.
-
(2004)
European Journal of Health Economics
, vol.5
, pp. 175-182
-
-
Magazzini, L.1
Pammolli, F.2
Riccaboni, M.3
-
26
-
-
47649107602
-
Does re-importation reduce price differences for prescription drugs? Lessons from the European Union
-
Kyle M.K., Allsbrook J.S., Schulman K.A. Does re-importation reduce price differences for prescription drugs? Lessons from the European Union. Health Services Research 2008, 43(4):1308-1324.
-
(2008)
Health Services Research
, vol.43
, Issue.4
, pp. 1308-1324
-
-
Kyle, M.K.1
Allsbrook, J.S.2
Schulman, K.A.3
-
27
-
-
84887092573
-
-
Cambridge Pharma Consulting, IMS Intelligence
-
Pricing and Market Access Review 2005 2006, Cambridge Pharma Consulting, IMS Intelligence.
-
(2006)
Pricing and Market Access Review 2005
-
-
-
28
-
-
83055163268
-
Pharmaceutical policies in European countries in responds to the global financial crisis
-
Vogler S., Zimmermann N., Leopold C., de Joncheere K. Pharmaceutical policies in European countries in responds to the global financial crisis. Southern Med Review 2011, 4(2):22-32.
-
(2011)
Southern Med Review
, vol.4
, Issue.2
, pp. 22-32
-
-
Vogler, S.1
Zimmermann, N.2
Leopold, C.3
de Joncheere, K.4
-
29
-
-
0008348082
-
-
European Medicine Agency, European Medicine Agency
-
European Public Assessment Reports 2012, European Medicine Agency, European Medicine Agency. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/landing/epar_search.jsp%38mid=WC0b01ac058001d124.
-
(2012)
European Public Assessment Reports
-
-
-
30
-
-
84887116995
-
-
http://www.whocc.no/atc_ddd_index.
-
-
-
-
31
-
-
84887078610
-
-
Pharma Price Information (PPI) Service, Austrian Health Institute
-
Gesundheit Österreich GmbH 2012, Pharma Price Information (PPI) Service, Austrian Health Institute.
-
(2012)
Gesundheit Österreich GmbH
-
-
-
32
-
-
84887113470
-
-
General Social Insurance Act § 351c, Federal Law No. 189/1955 (in German)
-
Latest Change by Federal Law I No. 398/2011 2012, General Social Insurance Act § 351c, Federal Law No. 189/1955 (in German).
-
(2012)
Latest Change by Federal Law I No. 398/2011
-
-
-
34
-
-
84887041037
-
-
European Commission Pharmaceutical Sector Inquiry
-
European Commission Pharmaceutical Sector Inquiry. (2009). http://ec.europa.eu/.
-
(2009)
-
-
-
35
-
-
84887116836
-
Competition and regulation in the EU regulation of pharmaceuticals
-
Desogus C. Competition and regulation in the EU regulation of pharmaceuticals. European Studies in Law and Economics 2012, 2012.
-
(2012)
European Studies in Law and Economics
, pp. 2012
-
-
Desogus, C.1
-
36
-
-
79960151532
-
-
European School of Management and Technology, Berlin, Germany, ESMT White Paper no. 109-03
-
Friederiszick H., Tosini N., et al. An Economic Assessment of the Relationship Between Price Regulation and Incentives to Innovate in the Pharmaceutical Industry 2009, European School of Management and Technology, Berlin, Germany, ESMT White Paper no. 109-03.
-
(2009)
An Economic Assessment of the Relationship Between Price Regulation and Incentives to Innovate in the Pharmaceutical Industry
-
-
Friederiszick, H.1
Tosini, N.2
-
39
-
-
77954490639
-
Does pharmaceutical parallel trade serve the objectives of cost control?
-
Kanavos P., Kowal S. Does pharmaceutical parallel trade serve the objectives of cost control?. Eurohealth 2008, 14(8):22-26.
-
(2008)
Eurohealth
, vol.14
, Issue.8
, pp. 22-26
-
-
Kanavos, P.1
Kowal, S.2
|